Answers are grounded in this paper and cite their sources.
Evaluates immune checkpoint inhibitor therapy in patients with advanced renal cell carcinoma and end-stage renal disease, indicating treatment viability.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ishihara et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: